1.93
price down icon1.03%   -0.02
after-market Handel nachbörslich: 2.01 0.08 +4.15%
loading

Finanzdaten der Io Biotech Inc-Aktie (IOBT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
28.34%
20.20
28.18 23.48 21.85 17.92
Operating Income/Loss
28.34%
-20.20
-28.18 -23.48 -21.85 -17.92
Nonoperating Income/Loss
50.93%
1.155
2.354 1.366 1.206 1.286
Income/Loss From Continuing Operations Before Tax
26.28%
-19.04
-25.83 -22.12 -20.65 -16.64
Income Tax Expense/Benefit
17.56%
0.415
0.353 -0.439 0.532 0.406
Income/Loss From Continuing Operations After Tax
25.69%
-19.46
-26.18 -21.68 -21.18 -17.04
Net Income/Loss
25.69%
-19.46
-26.18 -21.68 -21.18 -17.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
775.05%
65.88
7.5288 50.17 28.82 28.82
Diluted Average Shares
775.05%
65.88
7.5288 50.17 28.82 28.82
Basic Earnings Per Share
6.25%
-0.30
-0.32 -0.43 -0.74 -0.59
Diluted Earnings Per Share
6.25%
-0.30
-0.32 -0.43 -0.74 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):